Juan Camilo Arjona Ferreira - Nov 7, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Stock symbol
OGN
Transactions as of
Nov 7, 2024
Transactions value $
-$36,340
Form type
4
Date filed
11/8/2024, 04:17 PM
Previous filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +6.45K +85.48% $0.00 14K Nov 7, 2024 Direct
transaction OGN Common Stock Tax liability -$36.3K -2.3K -16.44% $15.80 11.7K Nov 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -6.45K -33.33% $0.00 12.9K Nov 7, 2024 Common Stock 6.45K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Organon & Co. common stock.
F2 On November 7, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two installments on November 7, 2025 and November 7, 2026.